Predicting the stress-strain behaviour of zeolite-cemented sand based on the unconfined compression test using GMDH type neural network

Stabilizing sand with cement is considered to be one of the most cost-effective and useful methods of in-situ soil improvement, and the effectiveness is often assessed using unconfined compressive tests. In certain cases, zeolite and cement blends have been used; however, even though this is a fundamental issue that affects the settlement response of a soil, very few attempts have been made to assess the stress-strain behaviour of the improved soil. Also, the majority of previous studies that predicted the unconfined compressive strength (UCS) of zeolite cemented sand did not examine the effect of the soil improvement variables and strain concurrently. Therefore, in this paper, an initiative is taken to predict the relationships for the stress-strain behaviour of cemented and zeolite-cemented sand. The analysis is based on using the unconfined compression test results and Group Method of Data Handling (GMDH) type Neural Network (NN). To achieve this end, 216 stress-strain diagrams resulting from unconfined compression tests for different cement and zeolite contents, relative densities, and curing times are collected and modelled via GMDH type NN. In order to increase the accuracy of the predictions, the parameters associated with successive stress and strain increments are considered. The results show that the suggested two and three hidden layer models appropriately characterise the stress-strain variations to produce accurate results. Moreover, the UCS values derived from this method are much more accurate than those provided in previous approaches. Moreover, the UCS values derived from this method are much more accurate than those provided in previous approaches which simply proposed the UCS values based on the content of the chemical binders, compaction, and/or curing time, not considering the relationship between stress and strain. Finally, GMDH models can be considered to be a powerful method to determine the mechanical properties of a soil including the stre

Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

Chronic lung infection by Pseudomonas aeruginosa is the major severe complication in cystic fibrosis (CF) patients, where P. aeruginosa persists and grows in biofilms in the endobronchial mucus under hypoxic conditions. Numerous polymorphonuclear leukocytes (PMNs) surround the biofilms and create local anoxia by consuming the majority of O2 for production of reactive oxygen species (ROS). We hypothesized that P. aeruginosa acquires energy for growth in anaerobic endobronchial mucus by denitrification, which can be demonstrated by production of nitrous oxide (N2O), an intermediate in the denitrification pathway. We measured N2O and O2 with electrochemical microsensors in 8 freshly expectorated sputum samples from 7 CF patients with chronic P. aeruginosa infection. The concentrations of NO 3- and NO2- in sputum were estimated by the Griess reagent. We found a maximum median concentration of 41.8 μM N2O (range 1.4-157.9 μM N2O). The concentration of N2O in the sputum was higher below the oxygenated layers. In 4 samples the N2O concentration increased during the initial 6 h of measurements before decreasing for approximately 6 h. Concomitantly, the concentration of NO3- decreased in sputum during 24 hours of incubation. We demonstrate for the first time production of N2O in clinical material from infected human airways indicating pathogenic metabolism based on denitrification. Therefore, P. aeruginosa may acquire energy for growth by denitrification in anoxic endobronchial mucus in CF patients. Such ability for anaerobic growth may be a hitherto ignored key aspect of chronic P. aeruginosa infections that can inform new strategies for treatment and prevention. © 2014 Kolpen et al

Synthesis, characterization and nonlinear optical properties of silver/PVA nanocomposites

Silver/polyvinyl alcohol (PVA) nanocomposites are prepared via quick precipitation method, using hydrazine as a reducing agent. Preparing of silver/PVA nanocomposites by this method is done for the first time. The samples are characterized by Uv-Visible spectroscopy, X-ray diffraction (XRD), transmission electron microscopy (TEM). Nonlinear optical properties are carried out by Z-scan technique using a blue CW laser beam operated at wavelength 405 nm. It is shown that the synthesized samples have negative nonlinear refractive index and the magnitude is in the order of 10^-8. The nonlinear refractive index increases as amount of reducing agent increases

Optical Nonlinear Refractive Index of Laser-Ablated Gold Nanoparticles Graphene Oxide Composite

Gold nanoparticles were prepared in graphene oxide using laser ablation technique. The ablation times were varied from 10 to 40 minutes, and the particle size was decreased from 16.55 nm to 5.18 nm in spherical shape. The nanoparticles were capped with carboxyl and the hydroxyl groups were obtained from Fourier transform infrared spectroscopy. Furthermore, the UVvisible peak shifted with decreasing of nanoparticles size, appearing from 528 nm to 510 nm. The Z-scan technique was used to measure the nonlinear refractive indices of graphene oxide with different concentrations and a gold nanoparticle graphene oxide nanocomposite. Consequently, the optical nonlinear refractive indices of graphene oxide and gold nanoparticle graphene oxide nanocomposite were shifted from 1.63 × 10 −9 cm 2 /W to 4.1 × 10 −9 cm 2 /W and from 1.85 × 10 −9 cm 2 /W to 5.8 × 10 −9 cm 2 /W, respectively

Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran

Objectives: Reliable evidence is the keystone for any noncommunicable disease (NCD) prevention plan to be initiated. In this study we carried out a risk factor investigation based on the WHO Stepwise approach to Surveillance (STEPS). Methods: The study was conducted on 1000 adults between 15 and 64 years of age living in Ardabil province, north-west Iran during 2006, based on the WHO STEPS approach to surveillance of risk factors for NCD. At this stage only the first and second steps were carried out. Data were collected through standard questionnaires and methods analyzed using STATA version 8 statistical software package. Results: 29.0% of men and 2.6% of women were current daily tobacco smokers. The mean number of manufactured cigarettes smoked per day was 18.9 among current daily smokers. Smoking was most prevalent among men of low-income families and those of lower education The mean body mass index (BMI) was 26.6 kg/m2, and was significantly correlated with systolic blood pressure. 58.9% were overweight or obese; 18.0% had raised blood pressure and 3.7% had isolated systolic hypertension. The mean number of servings of fruit consumed per day was 1.1; 33.1% had low levels of activity. Combined risk factor analysis showed that 4.1%of participants were in the low-risk group (up to 5.1% among men and 3.2% among women).Those in the high-risk group comprised 25.6% in the 25- to 44-year age group and 49.7%in the 45- to 64-year age group. Mean BMI increased by age in both sexes at least at the firstthree decades of adult life. Conclusion: Based on observed status of risk for cardiovascular health, burden of cardiovascular diseases is expected to increase if an effective prevention strategy is not undertaken

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran

Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in 2009 year.This is a prevalence-based cost-of-illness study focusing on quantifying direct health care costs by bottom-up approach. Data on inpatient hospital services, outpatient clinic visits, physician services, drugs, laboratory test, education and non-medical cost were collected from two national registries. The human capital approach was used to calculate indirect costs separately in male and female and also among different age groups.The total national cost of diagnosed T2DM in 2009 is estimated at 3.78 billion USA dollars (USD) including 2.04±0.28 billion direct (medical and non-medical) costs and indirect costs of 1.73 million. Average direct and indirect cost per capita was 842.6±102 and 864.8 USD respectively. Complications (48.9%) and drugs (23.8%) were main components of direct cost. The largest components of medical expenditures attributed to diabetes's complications are cardiovascular disease (42.3% of total Complications cost), nephropathy (23%) and ophthalmic complications (14%). Indirect costs include temporarily disability (335.7 million), permanent disability (452.4 million) and reduced productivity due to premature mortality (950.3 million).T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure. In addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life. Identification of effective new strategies for the control of diabetes and its complications is a public health priority

Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons

BACKGROUND/OBJECTIVES:In studies performed in mice, rose hip powder has been shown to both prevent and reverse high-fat diet-induced obesity and glucose intolerance as well as reduce plasma levels of cholesterol. The aim of this study was to investigate whether daily intake of rose hip powder over 6 weeks exerts beneficial metabolic effects in obese individuals.SUBJECTS/METHODS:A total of 31 obese individuals with normal or impaired glucose tolerance were enrolled in a randomized, double-blind, cross-over study in which metabolic effects of daily intake of a rose hip powder drink over 6 weeks was compared with a control drink. Body weight, glucose tolerance, blood pressure, blood lipids and markers of inflammation were assessed in the subjects.RESULTS:In comparison with the control drink, 6 weeks of daily consumption of the rose hip drink resulted in a significant reduction of systolic blood pressure (-3.4%; P=0.021), total plasma cholesterol (-4.9%; P=0.0018), low-density lipoprotein (LDL) cholesterol (-6.0%; P=0.012) and LDL/HDL ratio (-6.5%; P=0.041). The Reynolds risk assessment score for cardiovascular disease was decreased in the rose hip group compared with the control group (-17%; P=0.007). Body weight, diastolic blood pressure, glucose tolerance, and plasma levels of high-density lipoprotein (HDL) cholesterol, triglycerides, incretins and markers of inflammation did not differ between the two groups.CONCLUSIONS:Daily consumption of 40 g of rose hip powder for 6 weeks can significantly reduce cardiovascular risk in obese people through lowering of systolic blood pressure and plasma cholesterol levels.European Journal of Clinical Nutrition advance online publication, 14 December 2011; doi:10.1038/ejcn.2011.203